HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,511,000 | -10.2% | 139,396 | -0.0% | 0.01% | -11.1% |
| Q2 2022 | $6,136,000 | +17.5% | 139,453 | +6.5% | 0.01% | +50.0% |
| Q1 2022 | $5,222,000 | +24.6% | 130,933 | +25.6% | 0.01% | +20.0% |
| Q4 2021 | $4,192,000 | -1.1% | 104,232 | +0.0% | 0.01% | -16.7% |
| Q3 2021 | $4,237,000 | -10.5% | 104,185 | -0.0% | 0.01% | 0.0% |
| Q2 2021 | $4,733,000 | +19.4% | 104,233 | +9.6% | 0.01% | 0.0% |
| Q1 2021 | $3,964,000 | -50.6% | 95,075 | -49.4% | 0.01% | 0.0% |
| Q4 2020 | $8,024,000 | +225.1% | 187,876 | +100.0% | 0.01% | +20.0% |
| Q3 2020 | $2,468,000 | +645.6% | 93,921 | +661.0% | 0.01% | +400.0% |
| Q2 2020 | $331,000 | +49.1% | 12,342 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $222,000 | +1.4% | 12,342 | 0.0% | 0.00% | – |
| Q4 2019 | $219,000 | +17.7% | 12,342 | +2.8% | 0.00% | – |
| Q3 2019 | $186,000 | -9.7% | 12,000 | 0.0% | 0.00% | – |
| Q2 2019 | $206,000 | +6.7% | 12,000 | 0.0% | 0.00% | – |
| Q1 2019 | $193,000 | +9.7% | 12,000 | 0.0% | 0.00% | – |
| Q4 2018 | $176,000 | -19.3% | 12,000 | 0.0% | 0.00% | – |
| Q3 2018 | $218,000 | +7.9% | 12,000 | 0.0% | 0.00% | – |
| Q2 2018 | $202,000 | -57.0% | 12,000 | -50.0% | 0.00% | -100.0% |
| Q1 2018 | $470,000 | – | 24,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |